You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
The use of modified unprocessed herbal and biological materials in complementary medicines
This consultation closed on 21 November 2007.
The Office of Complementary Medicines (OCM), in collaboration with the OCM / Industry Consultation Group (OICG), drafted an adjunct guideline to the Australian Regulatory Guidelines for Complementary Medicines (ARGCM): Guidance on the use of modified unprocessed herbal and biological materials in complementary medicines.Submissions on the adequacy or otherwise relevance of the draft document were sought between 7 and 21 November 2007.
This draft guidance document applies to unprocessed herbal and biological materials whose composition has been chemically modified to the extent that it is significantly different from the original material approved for use in Listed or Registered medicines.
The aim of the document is to provide guidance to sponsors, manufacturers and raw material suppliers regarding the need to undertake a safety assessment to ensure that unprocessed herbal and biological materials, which have a significantly different chemical composition to that presently approved for use in complementary medicines, are safe.